PNC Financial Services Group’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
KCM
PNC Financial Services Group's LEGN Position: Q3 2026 in Review
PNC Financial Services Group reduced its Legend Biotech (LEGN) stake by 0.51% in Q3 2026, selling an estimated $2.54K and leaving 23,217 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #1891.
PNC Financial Services Group first reported a position in LEGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $674K in Q2 2026. 198 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.
- PNC Financial Services Group held 23,217 shares of Legend Biotech worth $462K as of Q3 2026.
- PNC Financial Services Group sold 119 Legend Biotech shares in Q3 2026, an estimated $2.54K.
- Legend Biotech made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1891 holding.
- PNC Financial Services Group first reported a position in Legend Biotech in Q4 2021 and has held it in 20 quarters since.
- PNC Financial Services Group's Legend Biotech position peaked at $674K in Q2 2026.
- 198 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.